David DiGiusto

3.7k total citations
49 papers, 2.8k citations indexed

About

David DiGiusto is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, David DiGiusto has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 18 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in David DiGiusto's work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (14 papers) and Immune Cell Function and Interaction (11 papers). David DiGiusto is often cited by papers focused on Virus-based gene therapy research (14 papers), CAR-T cell therapy research (14 papers) and Immune Cell Function and Interaction (11 papers). David DiGiusto collaborates with scholars based in United States, United Kingdom and Australia. David DiGiusto's co-authors include Michael C. Jensen, Stephen J. Forman, Julie R. Ostberg, Michael Kalos, Laurence J.N. Cooper, Leslie Popplewell, Jamie R. Wagner, Marilyn L. Slovak, Philippa Marrack and Yongwon Choi and has published in prestigious journals such as Nature, Blood and The Journal of Immunology.

In The Last Decade

David DiGiusto

48 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David DiGiusto United States 20 1.3k 1.2k 1.0k 766 312 49 2.8k
Gwenn Danet-Desnoyers United States 21 1.6k 1.2× 1.2k 1.0× 1.1k 1.1× 711 0.9× 408 1.3× 38 3.1k
Mikhail Roshal United States 27 2.3k 1.8× 1.4k 1.2× 862 0.8× 593 0.8× 469 1.5× 103 4.3k
Kristen Hege United States 36 3.6k 2.8× 1.9k 1.6× 2.5k 2.4× 887 1.2× 518 1.7× 90 5.2k
Hans J. Stauss United Kingdom 42 2.9k 2.2× 1.5k 1.2× 3.6k 3.5× 1.2k 1.5× 271 0.9× 136 5.6k
Siok‐Keen Tey Australia 22 1.5k 1.2× 777 0.6× 1.1k 1.0× 605 0.8× 357 1.1× 63 2.6k
Carolina Berger United States 28 3.0k 2.3× 1.2k 1.0× 1.5k 1.5× 1.1k 1.5× 782 2.5× 49 3.9k
Ulrike Gerdemann United States 21 1.7k 1.3× 699 0.6× 1.3k 1.2× 648 0.8× 74 0.2× 47 2.8k
Salima Hacein‐Bey‐Abina France 31 1.1k 0.8× 2.1k 1.7× 1.1k 1.0× 2.1k 2.7× 111 0.4× 84 3.7k
Jennifer E. Adair United States 26 568 0.4× 1.3k 1.1× 314 0.3× 683 0.9× 143 0.5× 64 1.9k
Gabriela Plesa United States 26 2.9k 2.2× 1.8k 1.5× 1.4k 1.3× 1.3k 1.7× 829 2.7× 45 4.5k

Countries citing papers authored by David DiGiusto

Since Specialization
Citations

This map shows the geographic impact of David DiGiusto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David DiGiusto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David DiGiusto more than expected).

Fields of papers citing papers by David DiGiusto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David DiGiusto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David DiGiusto. The network helps show where David DiGiusto may publish in the future.

Co-authorship network of co-authors of David DiGiusto

This figure shows the co-authorship network connecting the top 25 collaborators of David DiGiusto. A scholar is included among the top collaborators of David DiGiusto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David DiGiusto. David DiGiusto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mantri, Sruthi, et al.. (2020). The Binns Program for Cord Blood Research: A novel model of cord blood banking for academic biomedical research. Placenta. 103. 50–52. 3 indexed citations
2.
Armstrong, Randall, et al.. (2017). Detection of Replication Competent Lentivirus Using a qPCR Assay for VSV-G. Molecular Therapy — Methods & Clinical Development. 8. 1–7. 17 indexed citations
3.
Kumar, Bijender, Mayra García, Lihong Weng, et al.. (2017). Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 32(3). 575–587. 328 indexed citations
4.
Davies, Benjamin M., James Smith, Anna French, et al.. (2017). An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol. Systematic Reviews. 6(1). 120–120. 8 indexed citations
5.
Smith, James, Anna Schuh, Benjamin M. Davies, et al.. (2016). A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics. Frontiers in Genetics. 6. 104–104. 11 indexed citations
6.
Scherer, Lisa, et al.. (2014). Optimized Lentiviral Vectors for HIV Gene Therapy: Multiplexed Expression of Small RNAs and Inclusion of MGMTP140K Drug Resistance Gene. Molecular Therapy. 22(5). 952–963. 20 indexed citations
7.
8.
Li, Lijing, Ludmila Krymskaya, Jianbin Wang, et al.. (2013). Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases. Molecular Therapy. 21(6). 1259–1269. 146 indexed citations
9.
DiGiusto, David & Hans‐Peter Kiem. (2012). Current translational and clinical practices in hematopoietic cell and gene therapy. Cytotherapy. 14(7). 775–790. 6 indexed citations
10.
Gardner, Agnes, et al.. (2012). Optimized Processing of Growth Factor Mobilized Peripheral Blood CD34+ Products by Counterflow Centrifugal Elutriation. Stem Cells Translational Medicine. 1(5). 422–429. 5 indexed citations
11.
Zhang, Jane, et al.. (2012). Endogenous MCM7 MicroRNA Cluster as a Novel Platform to Multiplex Small Interfering and Nucleolar RNAs for Combinational HIV-1 Gene Therapy. Human Gene Therapy. 23(11). 1200–1208. 19 indexed citations
12.
Scuto, Anna, Maciej Kujawski, Claudia Kowolik, et al.. (2011). STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma. Cancer Research. 71(9). 3182–3188. 92 indexed citations
13.
Jensen, Michael C., Leslie Popplewell, Laurence J.N. Cooper, et al.. (2010). Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans. Biology of Blood and Marrow Transplantation. 16(9). 1245–1256. 430 indexed citations
14.
Тодоров, Иван, et al.. (2007). Human Marrow-Derived Mesodermal Progenitor Cells Generate Insulin-Secreting Islet-Like Clusters In Vivo. Stem Cells and Development. 16(5). 757–770. 17 indexed citations
15.
DiGiusto, David & Laurence J.N. Cooper. (2007). Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. Cytotherapy. 9(7). 613–629. 18 indexed citations
16.
Burton, Luciana, et al.. (2007). Manufacturing of Large Numbers of Patient-specific T Cells for Adoptive Immunotherapy. Journal of Immunotherapy. 30(6). 644–654. 30 indexed citations
17.
Shih, Chu-Chih, David DiGiusto, Adam N. Mamelak, Thomas LeBon, & Stephen J. Forman. (2002). Hematopoietic Potential of Neural Stem Cells: Plasticity Versus Heterogeneity. Leukemia & lymphoma. 43(12). 2263–2268. 5 indexed citations
18.
Shih, Chu-Chih, David DiGiusto, & Stephen J. Forman. (2000). Ex Vivo Expansion of Transplantable Human Hematopoietic Stem Cells: Where Do We Stand in the Year 2000?. Journal of Hematotherapy & Stem Cell Research. 9(5). 621–628. 12 indexed citations
19.
Young, Judy, et al.. (1996). In vitro characterization of fetal hematopoietic stem cells: Range and kinetics of cell production from individual stem cells. Biotechnology and Bioengineering. 50(5). 465–478. 6 indexed citations
20.
Ransom, John, et al.. (1988). Increased plasma membrane permeability to Ca2+ in anti-Ig-stimulated B lymphocytes is dependent on activation of phosphoinositide hydrolysis.. The Journal of Immunology. 140(9). 3150–3155. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gwenn Danet-Desnoyers Breakdown of academic impact, for papers by Mikhail Roshal Breakdown of academic impact, for papers by Kristen Hege Breakdown of academic impact, for papers by Hans J. Stauss Breakdown of academic impact, for papers by Siok‐Keen Tey Breakdown of academic impact, for papers by Carolina Berger Breakdown of academic impact, for papers by Ulrike Gerdemann Breakdown of academic impact, for papers by Salima Hacein‐Bey‐Abina Breakdown of academic impact, for papers by Jennifer E. Adair Breakdown of academic impact, for papers by Gabriela Plesa
Rankless by CCL
2026